Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity.
about
In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expressionSNARE-dependent upregulation of potassium chloride co-transporter 2 activity after metabotropic zinc receptor activation in rat cortical neurons in vitroThe zinc sensing receptor, a link between zinc and cell signalingSelective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zincIonotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkersRedox and trace metal regulation of ion channels in the pain pathwayMethods for recording and measuring tonic GABAA receptor-mediated inhibitionInhibition of the Prokaryotic Pentameric Ligand-Gated Ion Channel ELIC by Divalent CationsMolecular basis for zinc potentiation at strychnine-sensitive glycine receptorsProtein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma2 subunitsFragrant dioxane derivatives identify beta1-subunit-containing GABAA receptorsMolecular and biophysical basis of glutamate and trace metal modulation of voltage-gated Ca(v)2.3 calcium channels.Different forms of glycine- and GABA(A)-receptor mediated inhibitory synaptic transmission in mouse superficial and deep dorsal horn neuronsGABA and glycine as neurotransmitters: a brief history.An epilepsy-related region in the GABA(A) receptor mediates long-distance effects on GABA and benzodiazepine binding sites.Abnormal GABAA receptors from the human epileptic hippocampal subiculum microtransplanted to Xenopus oocytes.Zinc inhibition of gamma-aminobutyric acid transporter 4 (GAT4) reveals a link between excitatory and inhibitory neurotransmissionThe short splice variant of the gamma 2 subunit acts as an external modulator of GABA(A) receptor function.GABA coordinates with insulin in regulating secretory function in pancreatic INS-1 β-cells.Menthol enhances phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey neurons.Trafficking and potential assembly patterns of epsilon-containing GABAA receptors.An intersubunit zinc binding site in rat P2X2 receptorsBenzodiazepine modulation of partial agonist efficacy and spontaneously active GABA(A) receptors supports an allosteric model of modulation.Synaptically released zinc gates long-term potentiation in fear conditioning pathways.Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restrictionPharmacological characterisation of murine α4β1δ GABAA receptors expressed in Xenopus oocytes.Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus.GABA(A) receptor modulation by terpenoids from Sideritis extracts.GABAA receptor subunit profiles of tangentially migrating neurons derived from the medial ganglionic eminence.Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptorFunctional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes.The TM2 6' position of GABA(A) receptors mediates alcohol inhibition2'-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(A) receptors.Neurosteroids and GABA-A Receptor Function.Zinc-specific autometallographic in vivo selenium methods: tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells.Studies of ethanol actions on recombinant delta-containing gamma-aminobutyric acid type A receptors yield contradictory resultsDiscovery of allosteric modulators for GABAA receptors by ligand-directed chemistry.The neurobiology of zinc in health and disease.Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population.Neonatal epilepsy syndromes and GEFS+: mechanistic considerations.
P2860
Q21093378-9295B6AB-4C22-4A37-B3B3-407257A39A50Q24617826-6EC8DEBD-16CC-48EC-8FD9-220BDA064B14Q24675201-9AB8D747-470A-4D94-891E-8342701D348EQ24677049-F7BD42D8-DAC2-4FBC-BCBB-7D0F6FD6EAE0Q26778336-370F12C2-8BF9-4AEA-92D1-7C79E7A26239Q26784089-410DA294-4887-418B-A481-CC7A2F5C1860Q26859850-A7A53BFC-F986-4E34-B20D-C3EF578C8CA0Q27675268-C45369AF-7BFE-421B-845F-E400FB014078Q28115785-2DB4011F-F4F2-439D-938B-CE066ED78E02Q28504846-9086C44F-5C9D-4B65-8374-E7E4C43A62C5Q28572529-DCF984D0-2CD5-4339-AA11-989008B6BA9CQ30425220-D127A7A3-2CE8-4C36-B637-7AF0DD9FD2B6Q30491994-5EEE20FA-5A56-444D-8392-CA1BE39F57BBQ30498662-C129D938-4099-4832-AFA4-BE2C4E7C0C15Q33574699-A5E907C1-5DFE-45D8-B61B-C2DA600DE686Q33850761-A297E3D2-7D54-431A-A7F3-1DF02C03821FQ33936295-4E55B990-1124-42F8-8D6B-C72A54635076Q33937098-6B3013F3-2850-4374-881E-4FD02D077EBAQ34059609-641947C9-87CA-4FDE-969A-30E9063051D3Q34399901-744A0087-DF80-4C63-BAE7-B0A83844C4AFQ34666487-7DF449A0-AB97-49E4-8D76-F011CEB0F0EDQ34682246-7B08FE54-251F-4968-8196-8CB2CAD8460EQ35049035-4BAE438D-F5BD-4D03-A2E9-F9E364EE5ACBQ35108146-70986CB5-A0D7-4F4A-8F20-9C44651C65E6Q35146447-EE323F72-DCF9-467C-A745-17430A1B4EE4Q35177102-C6F504D8-A766-4205-B02F-6D8B8497488BQ35220449-394E18D3-A6F5-4986-AF45-5CDF1A9EDD02Q35262443-01DCE052-89F6-4715-8C50-368AEDAF6362Q35457913-AE1B648F-1242-41A1-8F5F-F98614865BAEQ35583015-E8F82828-6A82-4877-9648-37695C4FA97DQ35583676-828A3A8C-34C1-4684-A4D1-3B21A2E841AAQ35688528-64BAAA48-B6A4-413A-8256-0C9E0F0353B7Q35853220-F46F6AB3-4EDC-408B-BEF5-AE6D74733D8CQ35971833-1CA33292-BA93-4D7E-B322-1EB0C7B1AADAQ36026294-B28542A2-9E86-4667-936D-06415C64F534Q36088170-560DF8F6-B6AA-4853-9A34-AE5932158EF5Q36104192-0A095262-F2F1-4628-AF2E-8DC12726F53EQ36126098-4E3155FC-D3C6-498D-A52E-E28F09422E74Q36131243-C1BC11FA-2F42-4F92-8E8F-6AE114A3E956Q36344256-6A55BA16-12A9-4674-8A74-D962C5FC07D7
P2860
Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Zinc-mediated inhibition of GABA
@nl
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@ast
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@en
type
label
Zinc-mediated inhibition of GABA
@nl
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@ast
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@en
prefLabel
Zinc-mediated inhibition of GABA
@nl
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@ast
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@en
P2093
P2860
P356
P1433
P1476
Zinc-mediated inhibition of GA ...... underlie subtype specificity.
@en
P2093
Alastair M Hosie
Emma L Dunne
Trevor G Smart
P2860
P2888
P304
P356
10.1038/NN1030
P407
P577
2003-04-01T00:00:00Z